PRUEBA RÁPIDA COMBINADA DE TRANSFERRINA Y SANGRE OCULTA EN HECES (FOB) - COFEPRIS Registration 474R2018 SSA
Access comprehensive regulatory information for PRUEBA RÁPIDA COMBINADA DE TRANSFERRINA Y SANGRE OCULTA EN HECES (FOB) (COMBINED RAPID STOOL OCCULT BLOOD AND TRANSFERRIN (FOB) TEST) in the Mexico medical device market through Pure Global AI's free database. This Clase III medical device is registered under COFEPRIS analysis ID 474R2018 SSA and manufactured by AMUNET, S.A. DE C.V.. The device was registered on February 20, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
PRUEBA RÁPIDA PARA LA DETECCIÓN SIMULTÁNEA Y CUALITATIVA DE LAS ENZIMAS DE TRANSFERRINA Y SANGRE OCULTA EN HECES (FOB), LOS CUALES PUEDEN SER ÚTILES PARA EL DIAGNÓSTICO DE TRASTORNOS GASTROINTESTINALES HEMORRÁGICOS.
RAPID TEST FOR SIMULTANEOUS AND QUALITATIVE DETECTION OF TRANSFERRIN AND FECAL OCCULT BLOOD (FOB) ENZYMES, WHICH MAY BE USEFUL FOR THE DIAGNOSIS OF GASTROINTESTINAL BLEEDING DISORDERS.